in 11 patients with severe angina pectoris a new beta-blocking drug , atenolol ( tenormin ; i.c.i.66082 ) , was found in a double-blind randomized trial to reduce significantly the frequency of anginal attacks ( p less than 0-001 ) and the amount of trinitrin consumed ( p less than 0-03 ) in comparison with practolol and placebo .
C0002962
angina pectoris
C0004147
atenolol